suvorexant (belsomra) Report issue

Small molecule Approved FDA First in Class
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB
Back

Drug Pricing Summary

VA Big4

$8.4650 - $8.4840

VA FSS

$11.0143 - $11.2007

NADAC

$12.2532 - $12.2906

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
suvorexant 10 mg (TABLET) $8.4723 VA Big4
  • BELSOMRA (30)
    		•  Merck Sharp & Dohme Corporation
    suvorexant 10 mg (TABLET) $11.2007 VA FSS
  • BELSOMRA (30)
    		•  Merck Sharp & Dohme Corporation
    suvorexant 10 mg (TABLET) $12.2532 NADAC brand
  • BELSOMRA (1)
    		•  Merck Sharp & Dohme Corp.
    suvorexant 15 mg (TABLET) $8.4650 VA Big4
  • BELSOMRA (30)
    		•  Merck Sharp & Dohme Corporation
    suvorexant 15 mg (TABLET) $11.2007 VA FSS
  • BELSOMRA (30)
    		•  Merck Sharp & Dohme Corporation
    suvorexant 15 mg (TABLET) $12.2794 NADAC brand
  • BELSOMRA (1)
    		•  Merck Sharp & Dohme Corp.
    suvorexant 20 mg (TABLET) $8.4723 VA Big4
  • BELSOMRA (30)
    		•  Merck Sharp & Dohme Corporation
    suvorexant 20 mg (TABLET) $11.2007 VA FSS
  • BELSOMRA (30)
    		•  Merck Sharp & Dohme Corporation
    suvorexant 20 mg (TABLET) $12.2850 NADAC brand
  • BELSOMRA (1)
    		•  Merck Sharp & Dohme Corp.
    suvorexant 5 mg (TABLET) $8.4840 VA Big4
  • BELSOMRA (30)
    		•  Merck Sharp & Dohme Corporation
    suvorexant 5 mg (TABLET) $11.0143 VA FSS
  • BELSOMRA (30)
    		•  Merck Sharp & Dohme Corporation
    suvorexant 5 mg (TABLET) $12.2906 NADAC brand
  • BELSOMRA (1)
    		•  Merck Sharp & Dohme Corp.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue